A recent study shows that there may be a more effective way to treat melanoma by using ascorbate (vitamin C) to increase DNA damage in cancer cells, leading to their death, according to co-corresponding author of the study Marcus Cooke, professor and chair in the Department of Molecular Biosciences.
2024
SkylineDx’s Merlin Assay stratifies Stage I/II cutaneous melanoma beyond SLNB for recurrence
ROTTERDAM, Netherlands, and SAN DIEGO, May 30, 2024 /PRNewswire/ — SkylineDx announces the presentation of groundbreaking data at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting.
Pembrolizumab/Vibostolimab Coformulation for Melanoma to be Discontinued
The phase 3 KeyVibe-010 study will discontinue the coformulation of pembrolizumab and vibostolimab treatment for high-risk melanoma due to futility.
Not all treatments created equal: Identifying barriers to immunotherapy for melanoma
Immunotherapy is an effective yet very expensive treatment for melanoma.